Transurethral needle ablation of the prostate (TUNA) was heralded as a minimally invasive alternative to transurethral resection of the prostate (TURP), but is now marketed as an alternative to ...
A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...
Closes $36 Million Registered Direct Offering. This article has been disseminated on behalf of Profound Medical Corp. and may include paid advertising. Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) ...
AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...
TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...
This month, Samsung Bioepis announced the European launch of Obodence (60 mg pre-filled syringe) and Xbryk (120 mg vial), ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that it has increased the size of its private placement previously ...
I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback